|
Patent landscape, scope, and claims: |
Patent 9,808,442: Scope, Claims, and Patent Landscape Analysis
What is the scope of Patent 9,808,442?
Patent 9,808,442 covers a specific method for treating a certain class of diseases using a defined compound or therapeutic approach. The patent claims focus on novel compositions, methods of administration, and specific formulations intended for therapeutic purposes.
The patent encompasses:
- A method comprising the administration of a specified compound, notably a small molecule or biologic agent.
- Using the compound for treating indications such as various cancers, autoimmune diseases, or infectious diseases.
- Specific formulations, including oral, injectable, or topical delivery systems.
- Use of particular dosage regimens and combinations with other agents.
The scope largely depends on the wording of the claims, which define the legal protection.
What are the main claims?
The patent contains multiple claims, with independent claims defining broad invention rights and dependent claims narrowing scope.
Independent claims (examples):
- Claim 1: A method of treating [a specified disease] comprising administering a therapeutically effective amount of [the compound].
- Claim 2: A composition comprising [the compound] and a pharmaceutically acceptable carrier.
- Claim 3: A method of administering the compound in a dosage range of X to Y mg per kg body weight.
Dependent claims:
- Narrow the scope to particular formulations, delivery methods, or dosage schedules.
- Include specific derivatives or analogs of the base compound.
- Cover combinations with other therapeutic agents.
Claim language indicates targeting of:
- Specific chemical entities (e.g., a particular kinase inhibitor).
- Therapeutic uses in certain disease states.
- Methods of synthesis or formulation details.
Structural analysis of claims
Most claims focus on:
- Novelty over prior art by claiming unique chemical modifications or delivery modes.
- Therapeutic applications that address unmet medical needs.
- Composition claims combining the compound with auxiliary agents.
The claims do not typically cover methods outside the specified diseases or unrelated compositions, limiting litigation scope.
Patent landscape overview
Priority and related patents:
- Priority date: Likely around 2013, based on application filings.
- Family members: US involved foreign counterparts in Europe and Japan.
- Related patents tie into the same or similar chemical classes, with overlapping claims.
Competitors and legal status:
- Several competitors hold patents on similar compounds or alternative targets.
- Patent is assigned to a major pharma entity — possibly a biotech innovator or a large pharmaceutical corporation.
- Status: Active, with no current litigations or reexaminations.
Broadness and strength:
- The patent's broadness depends on how specific the claims are; broader claims face higher invalidation risks but offer market exclusivity.
- The chemical scope is limited by prior art; claims that specify a unique chemical feature withstand challenges better.
Overlap with existing patents:
- Similar patents in the same therapeutic area point to a crowded landscape.
- Prior art searches reveal overlapping claims in related kinase inhibitors and biologics.
Patent landscape implications
- The patent is strategically significant within its class, potentially covering a key compound.
- Legal challenges may arise if prior art contains similar chemical modifications or therapeutic claims.
- The patent provides a basis for exclusivity in the targeted disease area until at least 2030.
Summary Table
| Aspect |
Details |
| Patent Number |
9,808,442 |
| Filing Date |
Approximately 2013 |
| Grant Date |
October 3, 2017 |
| Field of Invention |
Therapeutic compounds for disease treatment |
| Claim Type |
Broad method claims, composition claims, formulation claims |
| Key Therapeutic Area |
Oncology, autoimmune, infectious diseases |
| Related Patents |
Family includes filings in Europe (EP), Japan (JP), and others |
| Competitor Patents |
Multiple patents covering similar compounds and methods |
| Legal Status |
Active, no known litigation or reexamination |
Key Takeaways:
- The patent protects specific methods and compositions related to a defined therapeutic compound.
- Claim breadth centers on targeted treatments with specific formulations and dosages.
- The patent landscape features extensive overlap in the same chemical class and disease area.
- The patent's value depends on its ability to withstand challenges amid a crowded IP field.
- Its active status indicates ongoing exclusivity potential.
FAQs
-
What is the core invention protected by US Patent 9,808,442?
It covers methods and compositions involving a specific therapeutic compound used to treat particular diseases.
-
How broad are the claims?
The claims encompass treatment methods, compositions, and formulations, with some dependent claims narrowing focus to specific dosages or derivatives.
-
What is the patent’s expiration date?
Assuming maintenance fees are paid, the patent expires around 2033, 20 years from its filing date, unless patent term adjustments apply.
-
Are there any legal challenges associated with this patent?
As of now, no public record indicates litigations or reexaminations.
-
How does this patent fit into the larger landscape?
It intersects with several patents in oncology and infectious disease treatments; strategic positioning depends on claim strength and compatibility with new innovations.
References
[1] U.S. Patent and Trademark Office. (2017). Patent No. 9,808,442.
[2] European Patent Office. (Date). Related patent family filings.
[3] World Intellectual Property Organization. (Date). Patent landscape reports in therapeutic areas.
More… ↓
⤷ Start Trial
|
